WealthTrust Fairport’s Abiomed Inc ABMD Stock Holding History

WealthTrust Fairport’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-500	Closed	-$145K	–	575
2018 Q1	$145K	Buy	+500	New	+$127K	0.01%	169

Other funds holding ABMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

WealthTrust Fairport's ABMD Position: Q2 2018 in Review

WealthTrust Fairport sold out of Abiomed Inc (ABMD) in Q2 2018, closing a stake of 500 shares — an estimated $145K sold.

WealthTrust Fairport first reported a position in ABMD in Q1 2018 and held it in 1 quarter. The position peaked at $145K in Q1 2018. 527 funds tracked by Wall St. Rank hold ABMD as of Q2 2018.

WealthTrust Fairport reported no remaining Abiomed Inc position as of Q2 2018 after selling out during the quarter.
WealthTrust Fairport sold 500 Abiomed Inc shares in Q2 2018, an estimated $145K.
WealthTrust Fairport first reported a position in Abiomed Inc in Q1 2018 and held it in 1 quarter.
WealthTrust Fairport's Abiomed Inc position peaked at $145K in Q1 2018.
527 funds tracked by Wall St. Rank held Abiomed Inc as of Q2 2018.

Based on WealthTrust Fairport's 13F filing for Q2 2018, filed 28 Aug 2018.